Loading…
Tango Therapeutics, Inc. is projected to rise to $38.78 by 2027, a +27% move from its current price of $30.52. TNGX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $29.21 | $30.55 | $31.94 | +0.08% |
| Jul 13 | $28.70 | $30.57 | $32.56 | +0.17% |
| Jul 14 | $28.32 | $30.60 | $33.05 | +0.26% |
| Jul 15 | $28.01 | $30.62 | $33.48 | +0.34% |
| Jul 16 | $27.74 | $30.65 | $33.86 | +0.43% |
| Jul 17 | $27.50 | $30.68 | $34.22 | +0.51% |
| Jul 18 | $27.29 | $30.70 | $34.55 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $27.29 | $30.70 | $34.55 | +0.60% |
| Week 2 | $26.14 | $30.88 | $36.49 | +1.20% |
| Week 3 | $25.33 | $31.07 | $38.11 | +1.80% |
| Week 4 | $24.69 | $31.25 | $39.57 | +2.41% |
| Week 5 | $24.15 | $31.44 | $40.93 | +3.02% |
| Week 6 | $23.69 | $31.63 | $42.22 | +3.63% |
| Week 7 | $23.29 | $31.82 | $43.47 | +4.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tango Therapeutics, Inc. is a precision oncology company focused on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine-cooperative PRMT5 inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma.
It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Tango Therapeutics, Inc. (TNGX) operates in Healthcare. The current price is $28.73 and the market capitalization is $4.68B. The stock is ranked 1443. The long-range forecast points to a bullish price trajectory with meaningful upside by 2030 and beyond, as reflected in the year-by-year Avg prices and ROIs.
The near-term price outlook remains anchored by current trading activity, while the longer-term forecast envisions substantial appreciation in Avg price across multiple future years, highlighted by strong bullish signals in the decades ahead.
A major floor 62.3% below — a decisive break under it would weaken the trend.
The nearest floor, 34.5% below — buyers have tended to step in here.
The nearest ceiling, 7.8% above — a clean break opens room to run.
A major ceiling 34.0% above — clearing it would confirm fresh momentum.
Key TNGX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TNGX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.46 | Buy | $30.57 | Sell |
| MA 10 | $30.58 | Sell | $30.33 | Buy |
| MA 20 | $30.40 | Buy | $29.50 | Buy |
| MA 50 | $25.86 | Buy | $26.72 | Buy |
| MA 100 | $22.40 | Buy | $22.99 | Buy |
| MA 200 | $15.96 | Buy | $18.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.01 | Neutral |
| Stoch RSI (14) | 50.53 | Neutral |
| CCI (20) | 37.30 | Neutral |
| Williams %R (14) | -35.97 | Info |
| MACD (12,26,9) | -0.23 | Sell |
| ROC (12) | 9.40 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 64.03 | Neutral |
| TRIX (15) | 0.87 | Buy |
| Awesome (5,34) | 3.07 | Buy |
| Ultimate (7,14,28) | 54.43 | Neutral |
| Momentum (10) | 0.92 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 30.74 | Sell |
| ADX (14) | 16.50 | Neutral |
| ATR (14) | 1.08 | Info |
The 30-day technical picture is bullish. RSI(14) sits at 50, with the 50-day moving average at $25.38 and the 200-day moving average at $15.28. Support is identified at $19.65 and resistance at $32.90, framing a 30-day range from $20.24 to $40.78.
Annualized volatility is 100%. The combination of neutral to bullish sentiment in the near term and the established support/resistance levels suggests a cautious but constructive near-term setup for TNGX.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.91 | $30.52 | $49.80 | 0% | Neutral | |
| $29.06 | $38.78 | $55.69 | +27% | Bullish | |
| $41.36 | $57.97 | $87.98 | +90% | Bullish | |
| $52.48 | $76.65 | $121.39 | +151% | Bullish | |
| $57.31 | $86.87 | $142.54 | +185% | Bullish | |
| $65.27 | $102.41 | $173.25 | +236% | Bullish | |
| $60.58 | $98.19 | $170.69 | +222% | Bullish | |
| $63.72 | $106.53 | $189.77 | +249% | Bullish | |
| $75.92 | $130.77 | $238.21 | +328% | Bullish | |
| $82.41 | $146.12 | $271.71 | +379% | Bullish | |
| $109.66 | $223.01 | $451.52 | +631% | Bullish | |
| $292.39 | $649.76 | $1,484.20 | +20.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.91 | $30.52 | $38.75 | +0.00% |
| August 2026 | $27.71 | $33.28 | $41.45 | +9.05% |
| September 2026 | $27.14 | $32.98 | $41.80 | -0.92% |
| October 2026 | $28.16 | $34.57 | $44.46 | +4.82% |
| November 2026 | $30.30 | $37.51 | $48.84 | +8.51% |
| December 2026 | $30.31 | $37.82 | $49.80 | +0.83% |
Click any year to see its month-by-month TNGX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TNGX is projected to trade between $8.91 and $49.80, averaging $30.52 — a potential gain of 0% from today's $30.52. Price action looks broadly range-bound.
Tango Therapeutics, Inc.'s 2027 outlook centres on $38.78, within a $29.06 to $55.69 range. That is up +27% on the projected 2026 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, TNGX could reach as high as $87.98, with a base case around $57.97 and support toward $41.36 — roughly +90% from $30.52. Momentum favours further upside here.
Expect TNGX to range from $52.48 to $121.39 through 2029. The $76.65 average target implies a +151% move from current prices. That is up +32% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The TNGX price prediction for 2030 points to an average of $86.87 (low $57.31, high $142.54) — a potential gain of +185% on today's $30.52. Momentum favours further upside here.
In 2031, TNGX is projected to trade between $65.27 and $173.25, averaging $102.41 — a potential gain of +236% from today's $30.52. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Tango Therapeutics, Inc.'s 2032 outlook centres on $98.19, within a $60.58 to $170.69 range. That is -4% versus the projected 2031 average. That marks a +222% change versus current levels. Momentum favours further upside here.
By 2033, TNGX could reach as high as $189.77, with a base case around $106.53 and support toward $63.72 — roughly +249% from $30.52. Buyers look set to stay in control over this stretch.
Expect TNGX to range from $75.92 to $238.21 through 2034. The $130.77 average target implies a +328% move from current prices. That is up +23% on the projected 2033 average. Momentum favours further upside here.
The TNGX price prediction for 2035 points to an average of $146.12 (low $82.41, high $271.71) — a potential gain of +379% on today's $30.52. Buyers look set to stay in control over this stretch.
In 2040, TNGX is projected to trade between $109.66 and $451.52, averaging $223.01 — a potential gain of +631% from today's $30.52. That is up +53% on the projected 2035 average. Momentum favours further upside here.
Tango Therapeutics, Inc.'s 2050 outlook centres on $649.76, within a $292.39 to $1,484.20 range. That is up +191% on the projected 2040 average. That marks a +20.3x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in TNGX today (≈ 32.7654 TNGX) could be worth
$21,289.53
+$20,289.53 (+2029%) by 2050 · US Dollar
Based on the average projected TNGX price of $649.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TNGXwould be worth at today's price.
$1,000 invested in TNGX on Jul 10, 2025 (≈ 163.666118 TNGX) would be worth
$4,995.09
+$3,995.09 (+399.5%) today · 5.00× · US Dollar
Based on a TNGX entry price of $6.11 vs. today's $30.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.46 | $1,035.98 | +3.6% |
| 1 month ago | $28.68 | $1,064.16 | +6.4% |
| 3 months ago | $19.95 | $1,529.82 | +53.0% |
| 6 months ago | $10.66 | $2,863.04 | +186.3% |
| 1 year ago | $6.11 | $4,995.09 | +399.5% |
| All time (5.0y) ago | $11 | $2,774.55 | +177.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TNGX forecast.
Our base-case forecast reaches $61.00 around 2029.
Implied market cap at $61.00: $9.93B
The multi-year forecast shows bullish sentiment in the longer horizon, with supporting Avg prices and strong upside potential. The 2030 forecast carries a min of $53.56, an avg of $86.57, a max of $150.14, and an ROI of 201.3%; sentiment is BULLISH. The 2040 forecast shows an avg of $216.11 with a max of $473.48 and an ROI of 652.2%, also labeled BULLISH.
The 2050 forecast shows an avg of $643.18 with a max of $1,479.32 and an ROI of 2138.7%, again with a BULLISH sentiment.
These are estimates, not guarantees, and they reflect a path of notable appreciation under the provided assumptions.
Tap a question to reveal the answer.
2030 forecast: min $53.56, avg $86.57, max $150.14; ROI 201.3%; sentiment BULLISH.
For 2026 the forecast shows avg $28.73 with ROI 0 and sentiment NEUTRAL.
2030 max forecast is $150.14.
2040 forecast: min $97.25, avg $216.11, max $473.48; ROI 652.2%; sentiment BULLISH.
2050 forecast: min $289.43, avg $643.18, max $1,479.32; ROI 2138.7%; sentiment BULLISH.
Tango Therapeutics, Inc. Community Discussion
0Share your Tango Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.